COVID-19

Melanoma/Skin Cancer

Questions discussed in this category

Are there circumstances where you would recommend every 6 week dosing schedule for pembrolizumab monotherapy?

I am considering every 6 week pembrolizumab dosing in patients >70 years old in whom I want to reduce clinic visits for, especially in the context ...

3 Answers available

What is the most appropriate dose-fractionation for an early stage, progressive cutaneous squamous cell carcinoma of the nose in an elderly/frail patient in the setting of the COVID-19 pandemic?

How do counsel patients regarding potential for cartilage necrosis?

5 Answers available

Papers discussed in this category

Pract Radiat Oncol, 2019 Dec 09

Definitive and Postoperative Radiation Therapy for Basal and Squamous Cell Cancers of the Skin: Executive Summary of an American Society for Radiation Oncology Clinical Practice Guideline.

Radiother Oncol, 2010 Mar 23

Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: Analysis of 434 cases.

COVID-19

Melanoma/Skin Cancer

Questions discussed in this category

Papers discussed in this category

Related Topics in COVID-19